Real-Life real-life barriers to diagnosis of early mycosis fungoides: an international expert panel discussionBarriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
Name:
36399227.pdf
Size:
719.2Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Hodak, E.Geskin, L.
Guenova, E.
Ortiz-Romero, P. L.
Willemze, R.
Zheng, J.
Cowan, Richard A
Foss, F.
Mangas, C.
Querfeld, C.
Affiliation
Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Tel Aviv University, 39 Jabotinsky Street, Petah Tiqva, 49100, Tel Aviv, IsraelIssue Date
2022
Metadata
Show full item recordAbstract
Mycosis fungoides (MF) is a rare, primary cutaneous T-cell lymphoma that is challenging to diagnose due to its heterogeneous clinical presentation and complex histology. The subtlety of the initial clinical appearance of MF can result in diagnostic delays and hesitancy to refer suspected cases to specialist clinics. An unmet need remains for greater awareness and education. Therefore, an international expert panel of dermatologists, oncologists, hematologists, and dermatopathologists convened to discuss and identify barriers to early and accurate MF diagnosis that could guide clinicians toward making a correct diagnosis. Confirmation of MF requires accurate assessment of symptoms and clinical signs, and subsequent correlation with dermatopathological findings. This review summarizes the expert panel's guidance, based on the literature and real-life experience, for dermatologists to help include MF in their list of differential diagnoses, along with simple clinical and histopathologic checklists that may help clinicians to suspect and identify potential MF lesions and reduce diagnostic delays.Citation
Hodak E, Geskin L, Guenova E, Ortiz-Romero PL, Willemze R, Zheng J, et al. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. Am J Clin Dermatol. 2022 Nov 18:1-10. PubMed PMID: 36399227. Pubmed Central PMCID: PMC9673193 Diseases and Takeda, and speakers’ bureaus for Helsinn, Rafa and Takeda. LG has received research support from Helsinn Group, J&J, Mallinckrodt, Kyowa Kirin, Soligenix, Innate, miRagen, Galderma, Merck, BMS and Stratpharma; and has served on speakers’ bureaus for Helsinn Group and J&J, and scientific advisory boards for Helsinn Group, J&J, Mallinckrodt, Sanofi, Regeneron and Kyowa Kirin. EG has been a member of the scientific advisory board of Scailyte AG and has received grants and personal fees from Helsinn Healthcare, Kyowa Hakko Kirin and Takeda; and personal fees from Mallinckrodt Pharmaceuticals, Recordati, Novartis and Sanofi. PLO-R has served on advisory boards for Recordati Rare Diseases, Helsinn, 4SC, Innate Pharma, Kyowa Pharma Chemical Co., Takeda, miRagen Therapeutics and Actelion. RW has been a member of the scientific advisory board of Helsinn. JZ declares no conflicts of interest. RC has served as a consultant for Kyowa Kirin and as a member of the scientific advisory board for Helsinn Healthcare. FF has served as a consultant for Kyowa and Mallinkrodt. CM has served on advisory boards for Novartis, Helsinn, Bristol Myers Squibb, Sanofi and Pierre Fabre. CQ has served on advisory board/scientific committees for Helsinn, Bioniz, miRagen, Trillium and Kyowa Kirin; and has received research funding from Celgene. Epub 2022/11/19. eng.Journal
American Journal of Clinical DermatologyDOI
10.1007/s40257-022-00732-wPubMed ID
36399227Additional Links
https://dx.doi.org/10.1007/s40257-022-00732-wType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1007/s40257-022-00732-w
Scopus Count
Collections
Related articles
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
- Authors: Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C
- Issue date: 2014 Feb
- Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
- Authors: Vandergriff T, Nezafati KA, Susa J, Karai L, Sanguinetti A, Hynan LS, Ambruzs JM, Oliver DH, Pandya AG
- Issue date: 2015 May
- Impact of clinical photographs on the accuracy and confidence in the histopathological diagnosis of mycosis fungoides.
- Authors: Hadi R, Miller TI, May C, Lehman JS, Bennett DD, Piliang M, Chang O, Shinohara MM
- Issue date: 2021 Jul
- Influence of clinical and pathologic features on the pathologist's diagnosis of mycosis fungoides: a pilot study.
- Authors: Rovner R, Smith HL, Katz PJ, Liu V
- Issue date: 2015 Jul
- Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls.
- Authors: Alsayyah A
- Issue date: 2020 Aug